About
Biomotum develops wearable robotic rehabilitation devices (soft exoskeletons) designed for clinical use to improve walking function in individuals with neurologic impairments such as cerebral palsy and stroke. Their SPARK on-demand robotic system is being piloted with clinics and planned for international launch in 2026.
Explore Biomotum's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.